clinical trial · NCT07583563
An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
AcromegalyOctreotide subcutaneous depot
brief summary
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
started
Jun 1, 2026
primary completion
Jun 1, 2029
completion
Jun 1, 2029
last updated
Jun 4, 2026
official title
A Multi-Center, Multinational, Observational Study of Octreotide Subcutaneous Depot for the Treatment of Patients With Acromegaly
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol